Literature DB >> 26691120

Initiation of Heroin and Prescription Opioid Pain Relievers by Birth Cohort.

Scott P Novak1, Ricky Bluthenthal1, Lynn Wenger1, Daniel Chu1, Alex H Kral1.   

Abstract

We examined initiation patterns among different birth cohorts of people who used prescription opioids and heroin because of historical differences in drug use availability. We examined data from a community-based study of persons who inject drugs (n = 483) in California and a general population survey from the National Survey on Drug Use and Health (n = 1264) and found that individuals born after 1980 were more likely than were individuals born before 1980 to initiate opioids through nonmedical use of prescription opioids than heroin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26691120      PMCID: PMC4815622          DOI: 10.2105/AJPH.2015.302972

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Can prescription drug monitoring programs help limit opioid abuse?

Authors:  Hallam M Gugelmann; Jeanmarie Perrone
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

2.  Multimethod research from targeted sampling to HIV risk environments.

Authors:  R N Bluthenthal; J K Watters
Journal:  NIDA Res Monogr       Date:  1995

Review 3.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Authors:  Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

4.  Pain management: the fifth vital sign.

Authors:  P Lanser; S Gesell
Journal:  Healthc Benchmarks       Date:  2001-06

5.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-04       Impact factor: 17.586

6.  The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Authors:  Art Van Zee
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

7.  The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt; Steven P Kurtz
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

8.  The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.

Authors:  Jennifer R Havens; Carl G Leukefeld; Angela M DeVeaugh-Geiss; Paul Coplan; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2014-02-26       Impact factor: 4.492

9.  Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment.

Authors:  Stephen F Butler; Theresa A Cassidy; Howard Chilcoat; Ryan A Black; Craig Landau; Simon H Budman; Paul M Coplan
Journal:  J Pain       Date:  2012-11-03       Impact factor: 5.820

10.  Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

Authors:  Paul M Coplan; Hrishikesh Kale; Lauren Sandstrom; Craig Landau; Howard D Chilcoat
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-09-30       Impact factor: 2.890

  10 in total
  15 in total

Review 1.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

2.  Anxiety sensitivity and opioid misuse and dependence among trauma-exposed adults with chronic pain.

Authors:  Michael J Zvolensky; Andrew H Rogers; Justin M Shepherd; Anka A Vujanovic; Jafar Bakhshaie
Journal:  J Behav Med       Date:  2020-02-18

3.  Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

4.  Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.

Authors:  Stephanie Lake; Thomas Kerr; Ekaterina Nosova; M-J Milloy; Evan Wood; Kora DeBeck
Journal:  J Urban Health       Date:  2018-04       Impact factor: 3.671

5.  Nonmedical prescription opioids and pathways of drug involvement in the US: Generational differences.

Authors:  Melanie Wall; Keely Cheslack-Postava; Mei-Chen Hu; Tianshu Feng; Pamela Griesler; Denise B Kandel
Journal:  Drug Alcohol Depend       Date:  2017-11-27       Impact factor: 4.492

6.  Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users.

Authors:  Sterling L Karakula; Roger D Weiss; Margaret L Griffin; Allison M Borges; Allen J Bailey; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2016-10-17       Impact factor: 4.492

7.  Drug use in business bathrooms: An exploratory study of manager encounters in New York City.

Authors:  Brett Wolfson-Stofko; Alex S Bennett; Luther Elliott; Ric Curtis
Journal:  Int J Drug Policy       Date:  2016-10-18

8.  Opioid Use Initiation, Progression, and Motivations Among OEF/OIF/OND-Era Veterans in New York City: An Age-Period-Cohort Analysis.

Authors:  Luther Elliott; Andrew Golub; Alexander Bennett
Journal:  Mil Behav Health       Date:  2017-07-18

9.  Prescription opioids prior to injection drug use: Comparisons and public health implications.

Authors:  Alia A Al-Tayyib; Stephen Koester; Paula Riggs
Journal:  Addict Behav       Date:  2016-08-19       Impact factor: 3.913

10.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.